A physician who met co-founders at Novartis and co-founded Arxx Therapeutics targeting inflammation and fibrosis; when Arxx merged with Oxitope Pharma in 2024 to form Calluna, he continued as co-founder and Chief Medical Officer.
Before
Co-founder and Chief Medical Officer at Arxx Therapeutics